Cruiser Capital Advisors has joined forces with a prior activist campaign to push Ashland Inc. toward a sale, escalating pressure on the specialty‑chemicals firm.

The move follows an earlier call from another activist investor, signaling that shareholders increasingly doubt Ashland’s growth prospects. A forced divestiture could unlock value for investors but also reshape the company’s long‑term strategy.

Market observers warn that a sale could trigger a wave of M&A activity in the chemicals sector, as competitors eye opportunities to consolidate. Investors will monitor Ashland’s board response closely, as the outcome may influence valuation benchmarks for similar firms.

The escalation underscores a broader trend of activist involvement in mid‑cap companies, reminding boards that shareholder sentiment can swiftly shift a company’s trajectory.